Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of TRU-016 in patients
with previously treated chronic lymphocytic leukemia, and to obtain an estimate of clinical
activity in patients with CLL and non-Hodgkin's lymphoma.